Clinical trial
Renal Tumors Classification, Biology, and Banking Study
NCT00898365 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Renal Tumors Classification, Biology, and Banking Study
- Lead sponsor
- Children's Oncology Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 27, 2006
- Completion date
- March 31, 2026
- Enrollment
- 8,000 (estimated)
- Sites
- 248
Conditions
As the registry lists them; a condition with its own page is linked.
adult cystic nephroma, anaplastic kidney wilms tumor, angiolipoma, cellular congenital mesoblastic nephroma, classic congenital mesoblastic nephroma, clear cell sarcoma of the kidney, congenital mesoblastic nephroma, cystic partially differentiated kidney nephroblastoma, diffuse hyperplastic perilobar nephroblastomatosis, extrarenal rhabdoid tumor, kidney medullary carcinoma, kidney neoplasm, kidney oncocytoma, kidney wilms tumor, metanephric adenofibroma, metanephric adenoma, metanephric stromal tumor, metanephric tumor, mixed congenital mesoblastic nephroma, ossifying renal tumor of infancy, papillary renal cell carcinoma, renal cell carcinoma, renal cell carcinoma associated with xp11.2 translocations/tfe3 gene fusions, rhabdoid tumor of the kidney, wilms tumor